Difference between revisions of "Actin (TG2)"
(pdf) |
|||
| Line 1: | Line 1: | ||
| − | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| Line 36: | Line 35: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | [ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] (pdf) |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 10:49, 17 July 2007
| Template:Infobox header| Actin (TG2) | |
|---|---|
| Actin (TG2) | |
| Substrate peptide name | Actin (TG2) |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytoskeleton |
| Swissprot ID | P08865 |
| Reactive glutamines | Q41 |
| Reactive lysines | Not determined yet |
| Substrate sequence | GRPRHQGVMVG |
| Structure | 2BTF |
| Surface accessibility | ASAView (pdf) |
| Disorder prediction | IUPred |
| Reference | PMID:9252372 |
| Notes | |
| Template:Infobox header | | |
.png){kind=link}